SCHEMBL4643399

SCHEMBL4643399

CCCC(CC)OC(=O)c1cc(Cl)c(Br)cc1C(=O)OC(CC)CCC

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 2/20 0.49
PRKCD Q05655 2/20 0.49
L3MBTL1 Q9Y468 1/20 0.36
HPGD P15428 2/20 0.34
MEN1 O00255 2/20 0.34
ALDH1A1 P00352 2/20 0.34
KMT2A Q03164 2/20 0.34
LMNA P02545 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.33
MAOB P27338 1/20 0.32
CYP1A2 P05177 1/20 0.32
GSK3B P49841 1/20 0.32
PTPN2 P17706 1/20 0.31
PTPN1 P18031 1/20 0.31
PTPN11 Q06124 1/20 0.31
CYP4F2 P78329 1/20 0.31
CYP4A11 Q02928 1/20 0.31
UTS2R Q9UKP6 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4643402 0.95 PRKCA (0.45) PRKCAPRKCDL3MBTL1HPGDMEN1
SCHEMBL4641146 0.90 PRKCA (0.55) PRKCAPRKCDHPGDMEN1ALDH1A1
SCHEMBL4641115 0.90 PRKCA (0.55) PRKCAPRKCDL3MBTL1MEN1ALDH1A1
SCHEMBL4639954 0.89 PRKCA (0.38) PRKCAPRKCDL3MBTL1HPGDMEN1
SCHEMBL4639956 0.84 PRKCA (0.35) PRKCAPRKCDL3MBTL1HPGDMEN1
SCHEMBL4627358 0.84 PRKCA (0.50) PRKCAPRKCDL3MBTL1HPGDMEN1
SCHEMBL4641148 0.84 PRKCA (0.50) PRKCAPRKCDMEN1ALDH1A1KMT2A
SCHEMBL4627321 0.84 PRKCA (0.50) PRKCAPRKCDHPGDALDH1A1UTS2R
SCHEMBL4641116 0.84 PRKCA (0.50) PRKCAPRKCDL3MBTL1MEN1ALDH1A1
SCHEMBL4627210 0.84 PRKCA (0.50) PRKCAPRKCDL3MBTL1MEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1188739-B1 PHTHALIC DIESTER DERIVATIVES AND ELECTRON DONORS TOHO TITANIUM CO LTD (JP) 2008-08-13 EP disclosed
US-6670497-B2 Dialkyl (at least one of which is a C4-8 tertiary alkyl) ester of an alkyl- or halo-substituted phthalic acid; used in an olefin polymerization catalyst TOHO TITANIUM CO., LTD. (JP) 2003-12-30 US disclosed
US-20030036594-A1 Phthalic diester derivatives and electron donors TOHO TITANIUM CO., LTD. (JP) 2003-02-20 US disclosed
EP-1188739-A1 PHTHALIC DIESTER DERIVATIVES AND ELECTRON DONORS TOHO TITANIUM CO., LTD. (JP) 2002-03-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030036594-A1 Phthalic diester derivatives and electron donors HPD, ETFA, PPOX PRKCA 1200/4885PRKCD 552/4885L3MBTL1 4720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.